Targeted therapy proves effective against brain tumors in preclinical studies December 21, 2012, from ScienceDaily: Brain Tumor News Targeted therapy proves effective against brain tumors in preclinical studies Researchers have published the first evidence that inhibiting focal adhesion kinase with CFAK-Y15 can control the growth of glioblastoma tumors. View Source
